How Hyperbaric Oxygen Chambers Help Stroke Patients? (2025 Update)

Stroke is still the fourth leading cause of death and the primary cause of disability in the US. However, stroke recovery is a tough and lengthy journey that involves thorough rehabilitation and medical care. A promising treatment for stroke recovery is hyperbaric oxygen therapy (HBOT) with a hyperbaric oxygen chamber.
Understand Stroke And Its Symptoms
A stroke, also known as a cerebrovascular accident, is a condition that occurs when the blood supply to part of the brain is interrupted or reduced, starving brain tissue of oxygen and nutrients. This interruption may be caused by a blockage of blood flow or bleeding in the brain. Without prompt medical intervention, a stroke can lead to brain damage, disability, and even death. Common signs and symptoms of stroke include:

• Sudden numbness or weakness in the face, arms, or legs, especially on one side of the body.
• Sudden confusion, difficulty speaking, or difficulty understanding speech.
• Sudden visual impairment in one or both eyes.
• Sudden difficulty walking, dizziness, loss of balance, or lack of coordination.
• Sudden severe headache of unknown origin.

The Effects of Hyperbaric Oxygen Chambers for Stroke Treatment
Hyperbaric oxygen chambers can infuse pure oxygen into plasma, lymph, and cerebrospinal fluid within a pressure environment exceeding typical atmospheric levels. This enables the body to intake oxygen levels many times greater than those present in regular indoor air. Thus, hyperbaric chamber therapy aids in diminishing additional cell death, fostering recovery, and delivering essential oxygen to deprived brain tissue, muscles, and bones. 

• Improve oxygen delivery to damaged brain tissue: Oxygen is essential for the survival and function of brain cells. After a stroke, affected brain tissue is often starved of oxygen due to reduced blood flow. Hyperbaric oxygen therapy increases the amount of oxygen delivered to damaged brain tissue, which helps reduce further cell death and promotes healing.
• Reduce swelling and inflammation: After a stroke, the brain may undergo considerable swelling and inflammation, worsening nerve damage. HBOT possesses anti-inflammatory properties that aid in reducing brain swelling, potentially lessening additional damage and enhancing outcomes for stroke patients.
• Promote neuroplasticity: Stroke patients often experience deficits in motor function, speech, and cognition as a result of brain damage. HBOT may stimulate neuroplasticity by promoting the growth of new blood vessels and enhancing the brain’s ability to form new connections.

Related Studies and Cases
Dr. Shai Efrati of Tel Aviv University's Sackler School of Medicine conducted experiments to study this. The researchers divided 74 participants into two groups, six to 36 months after stroke. The first treatment group received HBOT from the start of the study. The second treatment group received no treatment for two months and then received two months of HBOT. Experimental results show that HBOT can significantly improve brain function in post-stroke patients. Even in long-term, advanced stages, it can help neurons strengthen and make new connections in damaged areas.


Brain imaging before and after HBOT treatment in stroke patients.

Conclusion
Existing research shows that many brain diseases are related to inefficient energy supply to the brain. The hyperbaric oxygen chamber can help people increase the oxygen content in their bodies. Hyperbaric oxygen therapy using a hyperbaric oxygen chamber, therefore, offers a promising adjunctive treatment option for stroke patients. While further research is needed to fully understand the long-term benefits and optimal treatment options for stroke patients, the potential therapeutic benefits of HBOT make it a promising area of research.

Journal Reference:
Shai Efrati, Gregori Fishlev, Yair Bechor, Olga Volkov, Jacob Bergan, Kostantin Kliakhandler, Izhak Kamiager, Nachum Gal, Mony Friedman, Eshel Ben-Jacob, Haim Golan. Hyperbaric Oxygen Induces Late Neuroplasticity in iPost-Strokeke Patients - Randomized, Prospective Trial. PLoS ONE, 2013; 8 (1): e53716 DOI: 10.1371/journal.pone.0053716